As 2025 unfolds, changes across the patent landscape are unfolding. From agency leadership transitions to proposed legislation and evolving ...

Participating on the call will be Vuzix' Chief Executive Officer and President Paul Travers and Chief Financial Officer Grant ...

Syntec Optics is providing critical optical manufacturing and sub-assembly processes to image laser light into our OEM's photonic integrated circuits (PICs), enabling the integration of photonic ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...

Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...

President Donald Trump’s pick to lead the US Patent and Trademark Office is setting off alarm bells for tech companies and ...

Law.com Radar detected an uptick in securities cases centering on the COVID-19 pandemic. Eight federal lawsuits were surfaced ...

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

An attorney for the federal government argued Wednesday that six two-factor authentication patents asserted in a lawsuit ...

STORY HIGHLIGHTS Wolfspeed settles patent infringement lawsuit with Purdue University. Company expects one-time charge in fiscal 2025 third quarter. Wolfspeed plans to lay off 180 workers amid ...

Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...